-
Nudging Our Way to Better Cancer Care
Researchers use insights from behavioral economics to encourage taking recommended actions in health care.
by Kevin McLaughlin
-
Post-surgery Option for Liver Cancer
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
by Thomas Celona
-
Chronic Stress and Cancer
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
by Thomas Celona
-
Forward Look
Progress in Personalized Cancer VaccinesStudy finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
by Thomas Celona
-
The HPV Vaccine Prevents Cancer. Why Do Many Cancer Survivors Not Get It?
A recent study investigated why some young cancer survivors did not want the HPV vaccine and how they can be better served.
by Pamela Rafalow Grossman
-
Forward Look
The Pitfalls of PolypharmacyMany older adults take multiple medications, which can potentially interfere with their cancer treatment.
by Ashley P. Taylor
-
Facts and Stats
Counting the CostCancer deaths linked to cigarette smoking account for millions of years in lost lives and billions of dollars in economic burden.
by Thomas Celona
-
Add It Up
Immunotherapy combination treatments are the first choice for treating many advanced cancers, and more combinations are coming.
by Kendall K. Morgan
-
Colorectal Cancer in Young People
While colorectal cancer incidence has gone down among older people, incidence rates have steadily increased for people under age 50. Younger people are more likely to be diagnosed at a later stage and have unique challenges that come with facing cancer in their prime.
by Erin O’Donnell
-
Men and Cancer
Researchers are striving to understand why men are more likely than women to get and die from many types of cancer.
by Charlotte Huff
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff